Clinical Trial Update: Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

View source ↗

Summary

This completed clinical trial compares rivaroxaban with the current standard of care therapy for the treatment of acute deep vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Venous Thrombosis

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Deep Vein Thrombosis, Venous Thrombosis | Status: COMPLETED